Treatment
Does early methylprednisolone in MS relapses improve long-term functional recovery?
sNfL for NEDA-3 prediction: a systematic review and meta-analysis
Improved Adherence and Digital Health Literacy with MSCopilot for MS Self-Monitoring
Features and Clinical Significance of CD8+CD20+ Cytotoxic T Cells in Multiple Sclerosis
Impact of delayed anti-CD20 start on brain and biomarker trajectories in MS
Treatment Effect of Frexalimab on NfL and Plasma Biomarkers in Relapsing MS at 2.5 Years
Phase 2 Safety and Efficacy of Frexalimab in Relapsing MS: 2.5-Year Results
Subgroup Analyses of the Phase 3 Tolebrutinib in nrSPMS HERCULES Trial
Mix of tDCS protocols could represent a new treatment for Multiple Sclerosis patients
Effectiveness of Cladribine in a real world setting from a Latin-American Country
Trends in DMT´s use in patients with multiple sclerosis in Colombia
Risk stratification in multiple sclerosis patients treated with natalizumab
Global Perspectives on Multiple Sclerosis and Related Disorders’ Care
Assessing Cognition and Affective Disorders in MS Patients Under Anti-CD20 Therapy
Efficacy of Ocrelizumab Across Progressive Multiple Sclerosis Phenotypes
Immunoglobulin and Neutrophil Trends During Long-Term Ocrelizumab Therapy in MS
Safety of Ocrelizumab in Pregnancy and Postpartum: Real-World Outcomes
Effectiveness of Subcutaneous vs Intravenous Natalizumab in the Swedish MS Registry
BTK inhibitors in multiple sclerosis: Sorting out the differences
Investigations
vWF halts NMOSD pathology via regulating complement activation
Circulating microRNA Profiles as Biomarkers of Disease Activity in Multiple Sclerosis
Serum Calprotectin-Biomarker of Inflammatory Activity and Treatment Response in MS
Circulating microRNAs as Biomarkers of Diroximel Fumarate Treatment Response in MS
Neuronal CCR5 promotes neurodegeneration in multiple sclerosis
AI-based handwriting analysis for non-invasive MS diagnosis and monitoring
NR4A Nuclear Receptors as neuroprotective targets along the neuraxis in progressive Multiple Sclerosis
S100A9 protein and neurodegeneration in progressive multiple sclerosis motor cortex
Investigating the effect of trial participation on clinical outcomes in MS: a UKMSR study
Exploring the influence of prior disease activity in OCT dynamics after treatment onset
Wearable sensors improve the detection of disability progression in multiple sclerosis
Clinical
Real-World Outcomes of High-Efficacy Therapies in Multiple Sclerosis: A Bolivian Single-Center Study
Demyelinating Diseases and Sjögren’s Syndrome: Clinical Intersections
Brain MRI to Detect Upper Cervical Cord Critical Demyelinating Lesions in Progressive MS
Cognition in multiple sclerosis : a survey on the implementation of cognitive assessment in clinical practice from the physicians and the patients point of view.
Effects of Tolebrutinib on Progression Independent of Relapse Activity in GEMINI Trials
Disease Trajectories of Primary and Nonactive Secondary Progressive Multiple Sclerosis
Fatigue in Colombian MS Patients. Exploring association with aging and disability
Kappa Free Light Chain index diagnostic concordance with OCB in suspected cases of MS
Application of the 2024 McDonald criteria in the International ACON
Redefining Disability Progression in Relapsing–Remitting MS: The Critical Role of PIA and Insights from PIRA
Altered structural connectivity and cognition in multiple sclerosis: a longitudinal study
Cervicothoracic Osteomyelitis with Subdural Extension on Ocrelizumab for MS
Clinical Characteristics and Urinary Symptom Management in Multiple Sclerosis
Determinants of SDMT Performance in People with Relapsing-Remitting or Progressive MS
Diagnostic Challenges in Balo’s Concentric Sclerosis: A Case Series
Functional Neurological Symptoms in Multiple Sclerosis: A Scoping Review
Late-onset Baló's concentric sclerosis: Diagnostic and treatment considerations
Limited LCBA for AQP4-IgG in LATAM: Implications for the Revised 2025 NMOSD criteria
Longitudinal evaluation of JCV Index: a retrospective study in 807 Brazilian MS patients
Pontine capillary telangiectasia on course of diagnosing multiple sclerosis
Regulatory neutrophils in multiple sclerosis and their role in immunosurveillance
Resting Motor Threshold Predicts Response to Rehabilitation + rTMS in Progressive MS